Dr. Babak Morvarid, MD

Dr. Morvarid practices at West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente.

Dr. Morvarid's NPI, 1780796292, was assigned on August 31, 2006. Dr. Morvarid graduated from Georgetown University School Of Medicine in 2001. Dr. Morvarid's New Jersey license number on file is 25MA08092900.

Dr. Morvarid's primary practice is West Los Angeles Medical Center, at 6041 Cadillac Ave, Los Angeles, CA 90034 in Los Angeles County. The practice phone is (213) 857-2201.

Dr. Morvarid's primary practice is West Los Angeles Medical Center in Los Angeles, California, part of Kaiser Permanente. Dr. Morvarid is also affiliated with Yale New Haven Hospital. The medical group on file is Southern California Permanente Medical Group. Dmand AI also links Dr. Morvarid to 2 more medical groups, 1 dialysis center and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morvarid practices, 4 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Morvarid's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Morvarid is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Morvarid's licenses on file in 8 states: New Jersey, California, Connecticut, Maine, New Hampshire, Colorado, New York and Oregon.

Dmand AI lists epilepsy among the conditions Dr. Morvarid treats.

CMS data shows 1,216 Medicare services from Dr. Morvarid across 18 procedure codes in 2020, for 20 Medicare patients. Medicare paid $132,213 for them.

CMS counts 20 Medicare patients who saw Dr. Morvarid in 2024. 75% of them have high blood pressure, and 55% have high cholesterol. Their average risk score is 2.25, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Morvarid's median patient age at 60, with 59% women.

In 2024, Dr. Morvarid wrote 853 Medicare Part D claims for 295 patients. 90% of them were for generic drugs. CMS names the drug for 623 of them, across 23 drugs with 11 or more claims each, at $83,562 in total drug cost. In 2023, CMS named 622 claims across 22 drugs.

Dr. Morvarid accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Morvarid as offering telehealth.

Dmand AI links 1 paper to Dr. Morvarid. Dr. Morvarid's most frequent co-author is Andrew S. Blum, MD, PhD.

CMS Open Payments shows 65 general payments to Dr. Morvarid from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. MDD US Operations, LLC paid the most, $268.

Dmand AI lists 2 awards for Dr. Morvarid, most recently Top Doctor in 2020.

Dr. Morvarid graduated from Georgetown University School Of Medicine in 2001. Dr. Morvarid is a member of AAN.

Dr. Morvarid is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Kaiser Permanente. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.